>> 全站文章索引 >> 第25页:
Paroxetine influences respiration in rats: implications for the treatment of panic disorder - [Marie Olsson, Kristina Annerbrink, Finn Bengtsson, Jan Hedner and Elias Eriksson]
Decreased social behaviour following 3,4-methylenedioxymethamphetamine (MDMA) is accompanied by changes in 5-HT2A receptor responsivity - [Eleanor J. Bull, Peter H. Hutson and Kevin C. F. Fone]
What has dry cough in common with pruritus? Treatment of dry cough with paroxetine - [Zbigniew Zylicz and Magorzata Krajnik]
Regulation of the norepinephrine transporter by chronic administration of antidepressants - [Saloua Benmansour, Alfonso V. Altamirano, David J. Jones, Teresa A. Sanchez, Georgianna G. Gould, Marie-Christine Pardon, David A. Morilak and Alan Frazer]
Once-daily high-dose pindolol for SSRI-refractory depression - [Kenneth N. Sokolski, Janet C. Conney, Brenda J. Brown and Edward M. DeMet]
Effect of paroxetine on a model of posttraumatic stress disorder in rats - [Takehito Sawamura, Kunio Shimizu, Masashi Nibuya, Tomoki Wakizono, Go Suzuki, Tomoya Tsunoda, Yoshitomo Takahashi and Soichiro Nomura]
Resolution of paroxetine precursor using different lipases: Influence of the reaction conditions on the enantioselectivity of lipases - [Gloria Fernández-Lorente, José M. Palomo, Cesar Mateo, José M. Guisan and Roberto Fernandez-Lafuente]
Clastogenicity of selective serotonin-reuptake inhibitors - [Gokay Bozkurt, Ercan Abay, Ibrahim Ates, Goksel Karabogaz, Mevlut Ture, Fatma Oguz Savran, Sukru Palanduz, Kubra Temocin and Cetin Algunes]
The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test - [H. R. Sumnall, E. O]
Bupropion and paroxetine differentially influence cardiovascular and neuroendocrine responses to stress in depressed patients - [Patricia A. Straneva-Meuse, Kathleen C. Light, Michael T. Allen, Michael Golding and Susan S. Girdler]
Long term therapy of generalized anxiety disorder - [Frédéric Rouillon]
Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data - [Craig J Whittington, Tim Kendall, Peter Fonagy, David Cottrell, Andrew Cotgrove and Ellen Boddington]
Pindolol does not augment cortisol and prolactin responses to paroxetine in healthy subjects - [David J. Brunswick, David B. P. Goodman, John P. O]
Personality disorder and social anxiety predict delayed response in drug and behavioral treatment of panic disorder - [Peter Berger, Gabriele Sachs, Michaela Amering, Anita Holzinger, Bettina Bankier and Heinz Katschnig]
Serotonin transporter in substance P (neurokinin 1) receptor knock-out mice - [Boni, Stephen P. Hunt, Carmen De Felipe, Michel Hamon, Christian Jacquot, et al.]
Evaluation of the effect of chronic antidepressant treatment on neurokinin-1 receptor expression in the rat brain - [S. B. Sartori, P. W. J. Burnet, T. Sharp and N. Singewald]
Prenatal cocaine exposure potentiates paroxetine-induced desensitization of 5-HT2A receptor function in adult male rat offspring - [Zhuo Chen, Kate Waimey, Louis D. Van de Kar, Gonzalo A. Carrasco, Michelle Landry and George Battaglia]
Non-aqueous capillary zone electrophoresis method for the analysis of paroxetine, tamoxifen, and their main metabolites in urine - [J. Rodríguez Flores, J. J. Berzas Nevado, A. M. Contento Salcedo and M. P. Cabello Díaz]
Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development - [Yanling Xu, Youssef Sari and Feng C. Zhou]
Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus aureus efflux pumps - [Peng Wei, Glenn W. Kaatz and Robert J. Kerns]
Influence of menstrual cycle on platelet serotonin uptake site and serotonin2A receptor binding - [Anna-Carin Wihlb?ck, Inger Sundstr?m Poromaa, Marie Bixo, Per Allard, Tom Mj?rndal and Olav Spigset]
Heart rate variability in premenstrual dysphoric disorder - [Mikael Landén, Bertil Wennerblom, Hans Tygesen, Kjell Modigh, Karin S?rvik, Christina Ysander, Agneta Ekman, Hans Nissbrandt, Marie Olsson and Elias Eriksson]
Antihyperalgesic effects of cizolirtine in diabetic rats: behavioral and biochemical studies - [Bertrand Aubel, Valérie Kayser, Annie Mauborgne, Antonio Farré, Michel Hamon and Sylvie Bourgoin]
Worsening of depressive symptoms prior to randomization in clinical trials: a possible screen for placebo responders? - [Kenneth R Evans, Terrence Sills, Glen R Wunderlich and Heather P McDonald]
The association between panic disorder and the L/L genotype of catechol-O-methyltransferase - [Jong-Min Woo, Kyung-Sik Yoon, Young-Hee Choi, Kang-Sub Oh, Young-Sik Lee and Bum-Hee Yu]
Chronic treatment with fluvoxamine desensitizes 5-HT2C receptor-mediated hypolocomotion in rats - [Miki Yamauchi, Tomoko Tatebayashi, Kinuko Nagase, Maho Kojima and Taiichiro Imanishi]
NMR studies of the inclusion complex between β-cyclodextrin and paroxetine - [Andrea Bernini, Ottavia Spiga, Arianna Ciutti, Maria Scarselli, Giuseppe Bottoni, Paolo Mascagni and Neri Niccolai]
Development of a capillary gas chromatographic procedure - [J. J. Berzas, C. Guiberteau, M. J. Villase?or and V. Rodríguez]
Changes in anxiety sensitivity with pharmacotherapy for panic disorder - [Naomi M. Simon, Michael W. Otto, Jasper A. J. Smits, D. Colette Nicolaou, Hannah E. Reese and Mark H. Pollack]
Alterations in platelet serotonin transporter binding in women with postpartum onset major depression - [D. Jeffrey Newport, Michael J. Owens, David L. Knight, Kim Ragan, Neal Morgan, Charles B. Nemeroff and Zachary N. Stowe]
Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment - [E. Poulet, J. Brunelin, C. Boeuve, J. Lerond, T. D]
Incidence and duration of antidepressant-induced nausea: duloxetine compared with paroxetine and fluoxetine - [John Greist, Robert K. McNamara, Craig H. Mallinckrodt, Jyoti N. Rayamajhi and Joel Raskin]
Changes in lymphocyte subsets after short-term pharmacotherapy in patients with panic disorder - [Youl-Ri Kim, Quehn Park and Bum-Hee Yu]
On-Demand Treatment of Premature Ejaculation with Clomipramine and Paroxetine: A Randomized, Double-Blind Fixed-Dose Study with Stopwatch Assessment - [Marcel D. Waldinger, Aeilko H. Zwinderman and Berend Olivier]
Using sleep to evaluate comparative serotonergic effects of paroxetine and citalopram - [S. J. Wilson, J. E. Bailey, A. S. Rich, M. Adrover, J. Potokar and D. J. Nutt]
Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors - [Akira Kugaya, Gerard Sanacora, Julie K. Staley, Robert T. Malison, Ali Bozkurt, Shaukat Khan, Amit Anand, Christopher H. van Dyck, Ronald M. Baldwin, John P. Seibyl, et al.]
Concise synthesis of trans- and cis-3,4-disubstituted piperidines based on regio- and stereoselective allylation of cyclopentenyl esters - [Junji Igarashi, Hiroyuki Ishiwata and Yuichi Kobayashi]
In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain - [Kazufumi Hirano, Syuji Maruyama, Ryohei Kimura, Yoshiyuki Kagawa and Shizuo Yamada]
Liquid chromatography–electrospray ionisation mass spectrometry method for the determination of escitalopram in human plasma and its application in bioequivalence study - [Sonu Sundd Singh, Hiten Shah, Sapna Gupta, Manish Jain, Kuldeep Sharma, Purav Thakkar and Ruchy Shah]
Is dopamine a limiting factor of the antidepressant-like effect in the mouse forced swimming test? - [Caroline E. Renard, Eric Dailly, Bríd á. Nic Dhonnchadha, Martine Hascoet and Michel Bourin]
Memory deficit and reduced anxiety in young adult rats given repeated intermittent MDMA treatment during the periadolescent period - [Brian J. Piper and Jerrold S. Meyer]
The Neurotoxic Effects of 3,4-Methylenedioxymethamphetamine (MDMA) and Methamphetamine on Serotonin, Dopamine, and GABA-ergic Terminals: An In-Vitro Autoradiographic Study In Rats - [Brian D. Armstrong and Kevin K. Noguchi]
A comparative study of milnacipran and paroxetine in outpatients with major depression - [Daniel Sechter, Pierre Vandel, Emmanuel Weiller, Nicole Pezous, Fabienne Cabanac and Alain Tournoux]
Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial - [Michael J. Detke, Curtis G. Wiltse, Craig H. Mallinckrodt, Robert K. McNamara, Mark A. Demitrack and Istvan Bitter]
DA-8159 reverses selective serotonin reuptake inhibitor-induced erectile dysfunction in rats - [Gook Jun Ahn, Kyung Koo Kang, Dong Sung Kim, Byoung Ok Ahn, Won Bae Kim, Sung Keun Kang, Byeong Chun Lee and Woo Suk Hwang]
Platelet serotonin uptake and paroxetine binding among allelic genotypes of the serotonin transporter in alcoholics - [Martin A. Javors, Chamindi Seneviratne, John D. Roache, Nassima Ait-Daoud, Susan E. Bergeson, M. Consuelo Walss-Bass, Fatema Z. Akhtar and Bankole A. Johnson]
Role of the orbital cortex and of the serotonergic system in a rat model of obsessive compulsive disorder - [D. Joel, J. Doljansky, N. Roz and M. Rehavi]
Effects of chronic paroxetine pretreatment on (±)-8-hydroxy-2-(di-n-propyl-amino)tetralin induced c-fos expression following sexual behavior - [T.R. de Jong, T. Pattij, J.G. Veening, P.J.W.C. Dederen, M.D. Waldinger, A.R. Cools and B. Olivier]
Treatment with medications affecting dopaminergic and serotonergic mechanisms: Effects on fluency and anxiety in persons who stutter - [Sheila V. Stager, Karim Calis, Dale Grothe, Meir Bloch, Nannette M. Berensen, Paul J. Smith and Allen Braun]
Development and validation method for determination of fluoxetine and its main metabolite norfluoxetine by nonaqueous capillary electrophoresis in human urine - [J. Rodríguez Flores, J.J. Berzas Nevado, G. Casta?eda Pe?alvo and N. Mora Diez]
Nonaqueous capillary electrophoresis method for the analysis of tamoxifen, imipramine and their main metabolites in urine - [J. Rodríguez Flores, J.J. Berzas Nevado, A.M. Contento Salcedo and M.P. Cabello Díaz]
Coupling of human nicotinic acetylcholine receptors α7 to calcium channels in GH3 cells - [Dominik Feuerbach, Kurt Lingenh?hl, Peter Dobbins, Johannes Mosbacher, Nicola Corbett, Joachim Nozulak and Daniel Hoyer]
Characterization of serotonin transporter in blood lymphocytes of rats. Modulation by in vivo administration of mitogens - [Nemesio Cede?o, Mary Urbina, Francisco Obregón and Lucimey Lima]
Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis - [Emilio J Sanz, Carlos De-las-Cuevas, Anne Kiuru, Andrew Bate and Ralph Edwards]
The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors ? ARTICLE - [Fenghua Chen, Mads Breum Larsen, Connie Sánchez and Ove Wiborg]
Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone - [Zo? A. Hughes, Kathryn R. Starr, Christopher J. Langmead, Matthew Hill, Gerd D. Bartoszyk, James J. Hagan, Derek N. Middlemiss and Lee A. Dawson]
3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary–adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity - [Michael T. Williams, Tori L. Schaefer, Lisa A. Ehrman, Jessica A. Able, Gary A. Gudelsky, Renu Sah and Charles V. Vorhees]
Do venlafaxine XR and paroxetine equally influence negative and positive affect? - [Gabriel S. Dichter, Andrew J. Tomarken, Cathryn M. Freid, Stephanie Addington and Richard C. Shelton]
Synthesis, structural identification, and ligand binding of tropane ring analogs of paroxetine and an unexpected aza-bicyclo[3.2.2]nonane rearrangement product - [Scott P. Runyon, Jason P. Burgess, Philip Abraham, Kathryn I. Keverline-Frantz, Judy Flippen-Anderson, Jeffrey Deschamps, Anita H. Lewin, Hernán A. Navarro, John W. Boja, Michael J. Kuhar, et al.]
Breast cancer risk in a large cohort of female antidepressant medication users - [Reina Haque, Shelley M. Enger, Wansu Chen and Diana B. Petitti]
Determination of fluoxetine and its N-desmethyl metabolite in human plasma by high-performance liquid chromatography - [Laurian Vlase, Silvia Imre and Sorin Leucuta]
Dopaminergic mechanism of antidepressant action in depressed patients - [Paul Willner, Anthony S. Hale and Spilios Argyropoulos]
Treatment of vasomotor symptoms: Is there an alternative to hormone replacement therapy? - [Nadia F. Soliman]
Pharmacotherapy for major depression in children and adolescents - [Karen Dineen Wagner]
Anxiolytic suppression of repetitive transcranial magnetic stimulation-induced anxiety in the rats - [Koichi Isogawa, Minoru Fujiki, Jotaro Akiyoshi, Takashi Tsutsumi, Kensuke Kodama, Hirotaka Matsushita, Yoshihiro Tanaka and Hidenori Kobayashi]
Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients - [Solisbella Pe?a, Edith Baccichet, Mary Urbina, Isabel Carreira and Lucimey Lima]
Simultaneous determination of fluoxetine, citalopram, paroxetine, venlafaxine in plasma by high performance liquid chromatography–electrospray ionization mass spectrometry (HPLC–MS/ESI) - [He Juan, Zhou Zhiling and Li Huande]
Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder - [Francesca Brambilla, Carmen Mellado, Alessandra Alciati, Maria Giuseppina Pisu, Robert H. Purdy, Stefano Zanone, Giulia Perini, Mariarosa Serra and Giovanni Biggio]
Substance P in serum and cerebrospinal fluid of depressed patients: No effect of antidepressant treatment - [Michael Deuschle, Peter Sander, Inga Herpfer, Bernd L. Fiebich, Isabella Heuser and Klaus Lieb]
Solubility of paroxetine hydrochloride hemi-hydrate in (water + acetone) - [Guobin Ren, Jingkang Wang and Guizhi Li]
Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors - [David J. Johnson, Hans Sanderson, Richard A. Brain, Christian J. Wilson, Ketut (Jim) T. Bestari and Keith R. Solomon]
Duloxetine hydrochloride: A new dual-acting medication for the treatment of major depressive disorder - [Melanie E. Hunziker, Brandon T. Suehs, Tawny L. Bettinger and M. Lynn Crismon]
High- and low-affinity binding of S-citalopram to the human serotonin transporter mutated at 20 putatively important amino acid positions - [Per Plenge and Ove Wiborg]
Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects - [A. Gerdelat-Mas, I. Loubinoux, D. Tombari, O. Rascol, F. Chollet and M. Simonetta-Moreau]
Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer - [Isabelle Loubinoux, David Tombari, Jérémie Pariente, Angélique Gerdelat-Mas, Xavier Franceries, Emmanuelle Cassol, Olivier Rascol, Josette Pastor and Fran?ois Chollet]
Effects of continuous administration of paroxetine on ligand binding site and expression of serotonin transporter protein in mouse brain - [Kazufumi Hirano, Takahiro Seki, Norio Sakai, Yasuhiro Kato, Hisakuni Hashimoto, Shinya Uchida and Shizuo Yamada]
Reversal of Inappropriate Peripheral Vascular Responses in Hypertrophic Cardiomyopathy - [Rajesh Thaman, Perry M. Elliott, Jaymin S. Shah, Bryan Mist, Lynne Williams, Ross T. Murphy, William J. McKenna and Michael P. Frenneaux]
Influence of fluoxetine and paroxetine in behavioral sensitization induced by ethanol in mice - [F.O. Goeldner, G. Pigatto, A.F. Ribeiro, H.B. Machado and R. Boerngen-Lacerda]
Evaluation of the role of P-glycoprotein in the uptake of paroxetine, clozapine, phenytoin and carbamazapine by bovine retinal endothelial cells - [Lynn W. Maines, David A. Antonetti, Ellen B. Wolpert and Charles D. Smith]
α2-Adrenergic agonists antagonise the anxiolytic-like effect of antidepressants in the four-plate test in mice - [Fabienne Massé, Martine Hasco?t and Michel Bourin]
Differential effects of paroxetine on raphe and cortical 5-HT1A binding: A PET study in monkeys - [Giampiero Giovacchini, Lixin Lang, Ying Ma, Peter Herscovitch, William C. Eckelman and Richard E. Carson]
Differential effects of simultaneous or sequential administration of paroxetine and WAY-100,635 on ejaculatory behavior - [C. Looney, K.B. Thor, D. Ricca and L. Marson]
Effect of prolonged exposure to milnacipran on norepinephrine transporter in cultured bovine adrenal medullary cells - [Koji Shinkai, Reiji Yoshimura, Yumiko Toyohira, Susumu Ueno, Masato Tsutsui, Jun Nakamura and Nobuyuki Yanagihara]
Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine - [Jun-ichi Iga, Shu-ichi Ueno, Ken Yamauchi, Ikuyo Motoki, Sumiko Tayoshi, Koshi Ohta, Hongwei Song, Kyoko Morita, Kazuhito Rokutan and Tetsuro Ohmori]
Centrally active nonhormonal hot flash therapies - [Charles Loprinzi and Vered Stearns]
Separation-induced ultrasonic vocalization in rat pups: Further pharmacological characterization - [Michihiko Iijima and Shigeyuki Chaki]
The effect of pharmacotherapy on personality disorders in panic disorder: A one year naturalistic study - [Carlo Marchesi, Alessandro Cantoni, Stefania Fontò, Maria R. Giannelli and Carlo Maggini]
Depression treatment during outpatient visits by U.S. children and adolescents - [Jun Ma, Ky-Van Lee and Randall S. Stafford]
Efficacy and tolerability of controlled-release paroxetine in the treatment of severe depression: Post hoc analysis of pooled data from a subset of subjects in four double-blind clinical trials - [David L. Dunner, Alan Lipschitz, Cornelius D. Pitts and John T. Davies]
Development of a solid phase extraction for 13 ‘new’ generation antidepressants and their active metabolites for gas chromatographic–mass spectrometric analysis - [Sarah M.R. Wille, Kristof E. Maudens, Carlos H. Van Peteghem and Willy E.E. Lambert]
A new route to 3,4-disubstituted piperidines: formal synthesis of (-)-paroxetine and (+)-femoxetine - [Shinji Yamada and Ishrat Jahan]
Time course of dopamine D2 receptor occupancy by clozapine with medium and high plasma concentrations - [Akihiro Takano, Tetsuya Suhara, Ichiro Kusumi, Yoshito Takahashi, Yoshiyuki Asai, Fumihiko Yasuno, Tetsuya Ichimiya, Makoto Inoue, Yasuhiko Sudo and Tsukasa Koyama]
Fatty acids differentially affect serotonin receptor and transporter binding in the rat brain - [T.M. du Bois, C. Deng, W. Bell and X.-F. Huang]
Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male rats - [Trynke R. de Jong, Liselore J.A.E. Snaphaan, Tommy Pattij, Jan G. Veening, Marcel D. Waldinger, Alexander R. Cools and Berend Olivier]
Escitalopram versus paroxetine for social anxiety disorder: An analysis of efficacy for different symptom dimensions - [Dan J. Stein, Elisabeth Wreford Andersen and Malcolm Lader]
Desensitization of 5-HT2A receptor function by chronic administration of selective serotonin reuptake inhibitors - [Miki Yamauchi, Takako Miyara, Tetsuya Matsushima and Taiichiro Imanishi]
Selective serotonin re-uptake inhibition attenuates evoked glutamate release in the dorsal horn of the anaesthetised rat in vivo - [N.J. Langman, C.G.S. Smith and K.J. Whitehead]
Posttraumatic stress disorder: A state-of-the-science review - [Charles B. Nemeroff, J. Douglas Bremner, Edna B. Foa, Helen S. Mayberg, Carol S. North and Murray B. Stein]
Comparison of first refill rates among users of sertraline, paroxetine, and citalopram - [C. Daniel Mullins, Fadia T. Shaya, Fanlun Meng, Junling Wang and Morgan S. Bron]
Lack of Efficacy of the Substance P (Neurokinin1 Receptor) Antagonist Aprepitant in the Treatment of Major Depressive Disorder - [Martin Keller, Stuart Montgomery, William Ball, Mary Morrison, Duane Snavely, Guanghan Liu, Richard Hargreaves, Jarmo Hietala, Christopher Lines, Katherine Beebe, et al.]
分页: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 [25] 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40
41 42 43 44 45 46 47 48 49 50 |